The short version
7 companies supply this market — a reasonable cushion if one runs into trouble. The generic price is down 26% over the past year, to $4.66 per unit. The brand runs $17.96 per unit — 3.9× more. It is in shortage right now.
Market view
methylphenidate
27 marketed package NDCs · 7 active manufacturers
Most dispensed: HYDROCHLORIDE 20 mg · Capsule, Extended Release · #100 capsule, extended releases/bottle · HYDROCHLORIDE 10 mg · Capsule, Extended Release · #100 capsule, extended releases/bottle · HYDROCHLORIDE 40 mg · Capsule, Extended Release · #100 capsule, extended releases/bottle · HYDROCHLORIDE 30 mg · Capsule, Extended Release · #100 capsule, extended releases/bottle
Price range and competition
RSS: changes for this drugpriced separately — they are not the same market
Generic products only. Every company selling this drug reports its own price. The line follows the middle of the pack; the shaded band holds the middle half of companies — the wider it is, the more they disagree.
Latest · Sep 2026 — typical price $4.66 · middle half $2.07–$7.13 · full range $1.81–$7.89 · 16 products · 7 companies
ⓘ How this was built
Data sources
- CMS NADAC weekly survey + monthly archives back to 2013 (data.medicaid.gov)
- CMS Federal Upper Limit files (weighted AMP)
- FDA NDC Directory (openFDA) — maker roster
Method
Each month's band spans the NADAC unit prices of every NDC of this drug (min, quartiles, median, max), split into brand and generic cohorts by FDA marketing category. Maker counts come from distinct labelers with the NDC actively listed.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
What changed in the last 90 days
Every detected change for methylphenidate, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- Cotempla XR-ODTAug 19, 2026Price upNADAC $17.94865 → $17.98902 per unit (+0.22%)
- Cotempla XR-ODTAug 19, 2026Price downNADAC $18.03797 → $17.93549 per unit (-0.57%)
- Cotempla XR-ODTAug 19, 2026Price upNADAC $17.98761 → $18.07539 per unit (+0.49%)
- MethylphenidateAug 19, 2026Price downNADAC $2.12155 → $2.07756 per unit (-2.07%)
- MethylphenidateAug 19, 2026Price downNADAC $2.04191 → $2.02747 per unit (-0.71%)
- MethylphenidateAug 19, 2026Price downNADAC $1.84443 → $1.81233 per unit (-1.74%)
- MethylphenidateAug 19, 2026Price downNADAC $2.3402 → $2.30349 per unit (-1.57%)
- MethylphenidateAug 19, 2026Price downNADAC $2.12155 → $2.07756 per unit (-2.07%)
- MethylphenidateAug 19, 2026Price downNADAC $2.04191 → $2.02747 per unit (-0.71%)
- MethylphenidateAug 19, 2026Price downNADAC $1.84443 → $1.81233 per unit (-1.74%)
Same drug class
Other molecules FDA puts in Central Nervous System Stimulant, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- dextroamphetamine saccharate and amphetamine aspartate and dextroamphetamine sulfate and amphetamine sulfate· in shortage
- dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, amphetamine sulfate tablets, 10 mg,cll· in shortage
- dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, amphetamine sulfate tablets, 15 mg,cll· in shortage
- dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, amphetamine sulfate tablets, 20 mg,cll· in shortage
- dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, amphetamine sulfate tablets, 30 mg,cll· in shortage
- dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, amphetamine sulfate tablets, 5 mg,cll· in shortage
- lisdexamfetamine dimesylate capsules· in shortage
- lisdexamfetamine· in shortage
- amphetamine· in shortage
- dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate· in shortage
- dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate· in shortage
- dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate· in shortage
Common questions
- Is Methylphenidate in shortage right now?
- Yes. FDA currently lists Methylphenidate in shortage. This page is rebuilt every morning from FDA's shortage database.
- Who makes Methylphenidate?
- 7 companies have marketed Methylphenidate in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Methylphenidate cost?
- The typical pharmacy pays about $7.01 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
Shortage reports for this molecule
- In shortage now — Methylphenidate, Film, Extended Release, 10 mg (NDC 0574-2410-65)Feb 28, 2025
- In shortage now — Methylphenidate, Film, Extended Release, 15 mg (NDC 0574-2415-65)Feb 28, 2025
- In shortage now — Methylphenidate, Film, Extended Release, 20 mg (NDC 0574-2420-65)Feb 28, 2025
- In shortage now — Methylphenidate, Film, Extended Release, 30 mg (NDC 0574-2430-65)Feb 28, 2025
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.